New York Presbyterian contributes to telemedicine company Avizia's $6M round

By Heather Mack
Share

Telehealth platform provider Avizia has raised $6 million in Series A financing in a round led by HealthQuest Capital with additional investment from New York Presbyterian Hospital. Previously, the company raised $11 million, and this latest funding brings the series total to $17 million.

The funding will be used to expand Avizia’s platform for hospitals and other providers, the company said. Founded in 2013, Avizia spun out of Cisco and takes an approach similar to that used by Carena and Honeywell, which offer managed telemedicine offerings for providers. By combining all the elements of a telemedicine offering into one package, Avizia offers a platform that links mobile software, as well as traditional carts and peripherals, into a healthcare provider’s EHR and back-end systems.

“Telehealth is a proven way for hospitals to close gaps in care, reduce unnecessary ER visits, and expand their expertise and offerings outside of their current geography,” Avizia CEO and Cofounder Mike Baird said in a statement. “The funds we have raised in this Series A round will accelerate out efforts to expand our engineering teams and go to market reach to continually offer the best possible telehealth solutions for providers, and ultimately improve the health and quality of care delivered to the patients they serve.”

New York Presbyterian has been building up its telehealth services in recent years, leveraging the technology to reduce emergency room wait times and to conduct telestroke peer-to-peer physician consulting. With the investment, the healthcare system will expand its advising role to Avizia, guiding the company through its enhancement of its telemedicine platform.

“This investment represents an important step forward for New York Presbyterian and our digital health offerings,” NYP President and CEO Dr. Steven J. Corwin said in a statement. “We look forward to collaborating with Avizia and bringing the next generation of healthcare technology to patients in New York and around the country.”